{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-034328","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2022-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.768793+00:00","generated_at":"2026-06-24T23:51:15.974960+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CPHI receives NYSE American delisting notice for insufficient stockholders' equity","bullets":["Stockholders' equity was $5.3M as of March 31, 2022, below the $6.0M minimum required under Section 1003(a)(iii).","Company must submit a compliance plan by July 15, 2022 to regain compliance by December 15, 2023.","CPHI stock will continue trading on NYSE American under symbol CPHI with added '.BC' designation.","Failure to submit or comply with the plan may result in commencement of delisting proceedings."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-034328","json":"https://secwatch.observer/filing/0001213900-22-034328.json","markdown":"https://secwatch.observer/filing/0001213900-22-034328.md","text":"https://secwatch.observer/filing/0001213900-22-034328.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390022034328/0001213900-22-034328-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390022034328/ea161911-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:51:15.974960+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}